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Prognostic Value of Left Ventricular Diastolic Dysfunction in a
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Tatiana Kuznetsova, MD, PhD; Lutgarde Thijs, MSc; Judita Knez, MD; Lieven Herbots, MD, PhD; Zhenyu Zhang, MD;
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Background-—New techniques of Tissue Doppler Imaging (TDI) enable the measurement of myocardial velocities and provide
information about left ventricular (LV) diastolic function. Recent studies explored the prognostic role of TDI-derived indexes.
However, these studies considered only total mortality and did not provide information on cardiovascular mortality and morbidity.
Therefore, we investigated in continuous and categorical analyses whether Doppler diastolic indexes contained any prognostic
information over and beyond traditional cardiovascular risk factors in a general population.
Methods and Results-—We measured early and late diastolic peak velocities of mitral inflow (E and A) by conventional Doppler,
and the mitral annular velocities (e’ and a’) by TDI in 793 participants (mean age 50.9 years). We calculated multivariable-adjusted
hazard ratios for conventional and TDI Doppler indexes, while accounting for family cluster and cardiovascular risk factors. Median
follow-up was 4.8 years (5th to 95th percentile, 3.0 to 5.4). With adjustments applied for covariables, e’ velocity was a significant
predictor of fatal and nonfatal cardiovascular (n=59; P=0.004) and cardiac events (n=40; P=0.001). TDI e’ yielded a net
reclassification improvement of 54.2% for cardiovascular and 64.0% for cardiac events. Hazard ratios of all cardiovascular (2.21;
P=0.042) and cardiac (4.50; P=0.002) events were significantly elevated in participants with increased LV filling pressure
compared with subjects with normal diastolic function.
Conclusions-—TDI e’ velocity is a significant predictor of fatal and nonfatal cardiovascular events in a general population.
Furthermore, we observed an increase in all cardiovascular events in the diastolic dysfunction group characterized by elevated LV
filling pressure. ( J Am Heart Assoc. 2014;3:e000789 doi: 10.1161/JAHA.114.000789)
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T issue Doppler Imaging (TDI) enables the measurement ofmyocardial velocities and provide valuable information
about left ventricular (LV) diastolic function in addition to
classical M-mode, 2D echocardiography and pulsed-wave
Doppler (PWD). Impaired myocardial relaxation, an early stage
of LV diastolic dysfunction, is characterized by decreased
transmitral early (E peak), and enhanced atrial (A peak) LV
filling as well as less vigorous mitral annulus motion (e’) during
early diastole. Moreover, combining early transmitral flow
velocity with mitral annular velocity (E/e’ ratio) reflects
elevated LV filling pressure, another feature of LV diastolic
dysfunction. Community-based studies revealed a high-prev-
alence (up to 34.7%) LV diastolic dysfunction using compre-
hensive conventional and TDI echocardiographic imaging.1–4
In the Flemish Study on Environment, Genes and Health
Outcomes (FLEMENGHO), the frequency was 27.3%.3
Recent clinical studies explored the prognostic role of the
TDI-derived indexes in patients with different cardiovascular
diseases.5 TDI-derived e’ velocity and the E/e’ ratio have
independent prognostic value in patients with overt heart
failure,6–9 hypertension,10,11 or myocardial infarction.12 On
the other hand, population-based studies are essential to
determine the prognostic significance of subclinical LV
diastolic dysfunction. To our knowledge, only 2 community-
based studies4,13 explored the predictive value of TDI
velocities13 or LV diastolic dysfunction grades based on these
new indexes.4 However, outcome in these studies was
confined to total mortality.4,13 We, therefore, investigated in
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the FLEMENGHO cohort whether Doppler diastolic indexes
analyzed as continuous or categorical measures contained
prognostic information over and beyond traditional cardiovas-
cular risk factors.
Methods
Study Participants
The Ethics Committee of the University of Leuven approved the
Flemish Study on Environment, Genes and Health Outcomes
(FLEMENGHO). From August 1985 until December 2005, we
identified a random population sample-stratified by sex and age
from a geographically defined area in northern Belgium.3,14
Households, defined as those who lived at the same address,
were the sampling unit. We numbered households consecu-
tively, and generated a random-number list by use of SAS
random function. Households with a number matching the list
were invited; household members older than 18 years were
eligible. From 2005 to 2009, we invited 1031 former partici-
pants for a re-examination at our field center, including
echocardiography (Figure 1). We obtained informed written
consent from 828 subjects (participation rate, 80%). To study
the incidence of mortality and morbidity in relation to baseline
LV diastolic dysfunction, we invited these participants for a
follow-up examination on average 5 years after their first
echocardiographic examination. For this analysis, we excluded
16 subjects, because of atrial fibrillation (n=8) or the presence
of an artificial pacemaker (n=3), or because diastolic
function could not be reliably determined (n=4). We additionally
excluded 19 participants, because they were lost to follow-up
(Figure 1). Thus, the outcome cohort included 793 participants.
Echocardiography
The participants refrained from smoking, heavy exercise, and
drinking alcohol or caffeine-containing beverages for at least
3 hours before echocardiography. The blood pressure during
echocardiography was the average of 2 readings, obtained
with a validated OMRON 705IT device (Omron Corp) at the
end of the echocardiographic examination.
Data acquisition
One experienced physician (T.K.) did the ultrasound examina-
tion,3 using a Vivid7 Pro (GE Vingmed) interfaced with a
2.5- to 3.5-MHz phased-array probe, according to the
recommendations of the American Society of Echocardiogra-
phy.15 With the subjects in partial left decubitus and breathing
normally, the observer obtained images, together with a
simultaneous ECG signal, along the parasternal long and short
axes and from the apical 4- and 2-chamber long-axis views. All
recordings included at least 5 cardiac cycles and were
digitally stored for offline analysis. M-mode echocardiograms
of the LV were recorded from the parasternal long-axis view
under control of the 2-dimensional image. The ultrasound
beam was positioned just below the mitral valve at the level of
the posterior chordae tendineae. To record PWD mitral and
pulmonary vein (PV) flow velocities from the apical window
and the isovolumetric relaxation time (IVRT), the observer
positioned the Doppler sample volume at the mitral valve tips,
in the right superior PV, and between the LV outflow and
mitral inflow, respectively.
Using TDI, the observer recorded low-velocity, high-inten-
sity myocardial signals at a high frame rate (>190 FPS), while
adjusting the imaging angle to ensure a parallel alignment of
the ultrasound beam with the myocardial segment of interest.
From the apical window, the sonographer placed a 5-mm
Doppler sample at the septal, lateral, inferior, and posterior
sites of the mitral annulus.
Off-line analysis
The post-processing of echocardiograms was performed by
an observer (TK) blinded to the participants’ characteristics
in a few weeks after the initial examination. Digitally stored
images were analyzed using a workstation running the
EchoPac, version 4.0.4 software package (GE Vingmed). All
measurements were averaged over 3 heart cycles for
statistical analysis. The LV internal diameter and interven-
tricular septal and posterior wall thickness were measured
at end-diastole from the 2-dimensionally guided M-mode
Figure 1. Flowchart for participants in the study. FLEMENGHO
indicates Flemish Study on Environment, Genes and Health
Outcomes; FU, follow-up; LV, left ventricular.
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tracing. When optimal orientation of M-mode ultrasound
beam could not be obtained, the reader performed linear
measurements on correctly oriented 2-dimensional images.
End-diastolic LV dimensions were used to calculate LV mass
by an anatomically validated formula according to the
recommendations of the American Society of Echocardiog-
raphy.15 We calculated LV ejection fraction (EF) from LV
end-systolic and end-diastolic volumes measured from the
apical 4- and 2-chambers views, using the standard
Simpson’s method. We measured left atrial (LA) dimensions
in 3 orthogonal planes: the parasternal long, lateral, and
supero-inferior axes. LA volume (LAVI) was calculated using
the prolate-elipsoid method and was indexed to body
surface area.
From the transmitral flow signal, we measured peak early
diastolic velocity (E), peak late diastolic velocity (A), the E/A
ratio, and A flow duration. From the PV flow signal, we
measured the duration of PV reversal time during atrial
systole (AR). From the TDI recordings, we measured peaks
systolic (s’) and early (e’) and late (a’) diastolic mitral annular
velocities, and the e’/a’ ratio at the 4 acquisition sites (septal,
lateral, inferior, and posterior). We calculated the E/e’ ratio by
dividing transmitral E peak by e’ averaged from the 4
acquisition sites.
We combined the mitral inflow and TDI velocities to classify
the stages of LV diastolic dysfunction at baseline as
previously described.2,3 The first group included subjects
with an abnormally low age-specific transmitral E/A ratio
indicative of impaired relaxation, but without evidence of
increased LV filling pressures (E/e’≤8.5). The second group
had mildly-to-moderately elevated LV filling pressure (E/
e’>8.5), and E/A ratio within the normal age-specific range.
We also used the differences in durations between the mitral
A flow and the reverse PV flow during atrial systole
(Ad<ARd+10) and/or LA volume index (≥28 mL/m2) to
confirm possible elevation of the LV filling pressures in group
2. Group 3 had an elevated E/e’ ratio and an abnormally low
age-specific E/A ratio (combined dysfunction).
Assessment of Outcome
Outcomes were adjudicated against source documents, as
described in previous publications.16 We ascertained the
vital status of FLEMENGHO participants until December 31,
2012. During follow-up, 25 participants died. We obtained
the International Classification of Disease codes for the
immediate and underlying cause of death.16 In all partic-
ipants, we collected information on the incidence of nonfatal
events via a follow-up visit at the examination center
(n=665) or a telephone interview (n=103) with repeat
administration of the same standardized questionnaire used
at baseline. To assess the symptoms associated with heart
failure, we administered the standardized London School of
Hygiene cardiovascular, dyspnea and respiratory question-
naires.17 Physician ascertained the diseases reported on the
death certificates or by the questionnaires against the
medical records of general practitioners or hospitals.
Cardiac events included fatal and nonfatal myocardial
infarction, coronary revascularization, fatal and nonfatal
heart failure, new-onset angina (stable or unstable), cor
pulmonale, new-onset atrial fibrillation and life-threatening
arrhythmias. Fatal and nonfatal cardiovascular events com-
prised cardiac endpoints, stroke, transient ischemic attacks,
aortic aneurysm, arterial embolism, and revascularization of
peripheral arteries. The diagnosis of symptomatic heart
failure required the presence of symptoms or signs
compatible with heart failure, such as dyspnea, peripheral
edema, or pulmonary congestions. In the study participants
who experienced cardiovascular events (n=59), we only
considered the first event per participant.
Other Measurements
The conventional blood pressure was the average of 5
consecutive auscultatory readings obtained with the subject
in the seated position. Hypertension was defined as a blood
pressure of at least 140 mm Hg systolic or 90 mm Hg
diastolic or as the use of antihypertensive drugs. Body mass
index was weight in kilograms divided by the square of height
in meters. Venous blood samples were drawn for measure-
ment of blood glucose, serum total cholesterol, and NT-
proBNP. Diabetes mellitus was determined by self-reported
diagnosis, fasting glucose level of at least 126 mg/dL, or use
of antidiabetic agents. NT-proBNP was measured in plasma
samples by a competitive enzyme immunoassay for research
use (Biomedica Gruppe). The standard range provided by the
manufacturer of the EIA is from 0 to 1000 pmol/L (median,
208 pmol/L; 95th percentile, 300 pmol/L).
Statistical Methods
For database management and statistical analysis, we used
SAS software, version 9.3 (SAS Institute). We compared
means and proportions by means of a large sample z test and
the v2 statistics, respectively. Statistical significance was a 2-
sided significance level of 0.05.
In exploratory analyses, we plotted incidence rates by
quartiles of the Doppler diastolic indexes at baseline, while
standardizing for sex and age (age groups: <40 years; 40 to
60 years; >60 years) by the direct method. We used Cox
regression to compute standardized hazard ratios, which
express the risk associated with a 1-standard deviation (SD)
change in the Doppler diastolic indexes. The baseline charac-
teristics considered as covariables in Cox regression were sex,
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age, body mass index, systolic blood pressure, smoking, serum
cholesterol, diabetes mellitus, and a history of cardiac disease.
We checked the proportional hazard assumption using the
Kolmogorov-type supremum test. Clustering of failure times
within pedigrees was taken into account by fitting a sheared
frailty model. In the categorical analyses, we used the Kaplan-
Meier method for estimation of cumulative incidence accord-
ing to LV diastolic dysfunction group. The frailty Cox regression
model was applied to calculate adjusted hazard ratios in the LV
diastolic dysfunction groups using participants with normal
diastolic function as the reference group.
Finally, we assessed the added ability of the selectedDoppler
diastolic indexes to predict fatal and nonfatal cardiovascular
events, using the integrated discrimination improvement (IDI)
and the net reclassification improvement (NRI) as described by
Pencina et al.18 IDI is the difference between the discrimination
slopes of the basic model and the basic model extended with an
echocardiographic variable. The discrimination slope is the
difference in predicted probabilities (%) between subjects with
and without composite endpoints. To calculate the continuous
NRI,18 we predicted in each subject the 10-year risk for the
composite event from a Cox model with and without Doppler
diastolic index included. Let P(up/event) the percentage of
subjects with events whose predicted probability is increased
by adding the echocardiographic variable to the model and
P(up/nonevent) the percentage of subjects without events
whose predicted probability is increased. The NRI was then
calculated as 29[P(up/event)-P(up/nonevent)].
Results
Characteristics of Participants at Baseline
The study population consisted of 793 white Europeans. Of
the participants, 405 (51.5%) were women, and 327 (41.2%)
had hypertension of whom 200 (61.2%) were taking blood
Table 1. Characteristics of Participants
Clinical Measurements Echocardiographic Measurements
Characteristic Women (n=405) Men (n=388) P Value Characteristic
Women
(n=405) Men (n=388) P Value
Anthropometrics Conventional
echocardiography
Age, y 51.815.3 50.015.7 0.09 LA volume index, mL/m2 21.85.98 24.06.32 <0.0001
Height, cm 162.56.9 175.47.2 <0.0001 LV internal diameter, cm 4.830.39 5.250.52 <0.0001
Weight, kg 69.713.9 81.912.1 <0.0001 Interventricular septum, cm 0.930.15 1.040.17 <0.0001
Body mass index, kg/m2 26.34.7 26.63.71 0.33 Posterior wall, cm 0.850.13 0.950.14 <0.0001
Waist circumference, cm 86.112.4 94.310.6 <0.0001 Relative wall thickness 0.370.06 0.380.07 0.009
Systolic pressure, mm Hg 127.919.3 130.815.4 0.02 LV mass index, g/m2 85.019.5 100.321.9 <0.0001
Diastolic pressure, mm Hg 77.89.0 81.69.6 <0.0001 LVD volume index, mL/m2 48.08.65 58.210.7 <0.0001
Heart rate, beats/min 62.79.2 59.19.8 <0.0001 LVS volume index, mL/m2 17.64.34 22.25.46 <0.0001
Ejection fraction, % 64.26.4 62.46.8 0.0001
Questionnaire data Doppler data
Current smoking, n (%) 82 (20.3) 83 (21.4) 0.07 E peak, cm/s 78.815.7 71.815.8 <0.0001
Drinking alcohol, n (%) 85 (21.0) 230 (59.3) <0.0001 A peak, cm/s 68.817.4 60.816.5 <0.0001
Hypertensive, n (%) 159 (39.3) 168 (43.3) 0.25 E/A ratio 1.230.44 1.290.42 0.08
Treated for hypertension, n (%) 107 (26.4) 93 (24.0) 0.43 s’ peak*, cm/s 8.631.37 9.491.42 <0.0001
History of CHD, n (%) 9 (2.22) 16 (4.12) 0.13 e’ peak*, cm/s 11.33.55 11.53.76 0.44
History of diabetes, n (%) 16 (3.95) 11 (2.48) 0.39 a’ peak*, cm/s 9.891.98 10.32.19 0.004
Biochemical data e’/a’ ratio* 1.250.62 1.240.68 0.91
Serum creatinine, lmol/L 76.712.6 91.615.2 <0.0001 E/e’ ratio 7.512.35 6.651.88 <0.0001
Total cholesterol, mmol/L 5.40.98 5.10.95 <0.0001 IVRT, ms 96.615.9 98.917.2 0.06
NT-proBNP, pmol/L 218 (106 to 488) 192 (90 to 394) <0.0001 Δ(Adur-ARdur), ms 0.3812.4 0.9611.5 0.51
Values are mean (SD), number of subjects (%) or geometric mean (10% to 90% percentile interval). Adur indicates mitral inflow A-wave duration; ARdur, pulmonary vein reversal flow
duration; CHD, coronary heart disease; IVRT, isovolumetric relaxation time; LA, left atrium; LV, left ventricle; LVD, left ventricular diastolic; LVS, left ventricular systolic; NT-proBNP, amino
terminal pro-BNP.
*Averaged of septum, lateral, inferior and posterior mitral annulus sites.
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pressure-lowering drugs. The mean age was 50.9 (SD 15.5)
years. At baseline, 165 participants (20.8%) were current
smokers. A total of 27 (3.4%) had a history of cardiac diseases
and 27 (3.4%) had a history of diabetes mellitus. Six
participants (0.8%) had an EF of ≤50%. Table 1 shows the
baseline clinical and echocardiographic characteristics of the
study participants by sex.
Incidence of Events
In the study population, the median follow-up was 4.8 years
(5th to 95th percentile, 3.0 to 5.4). During 3628 person-years
of follow-up, 59 participants experienced either a fatal or
nonfatal cardiovascular endpoint (16.3 events per 1000 per-
son-years). A fatal or nonfatal cardiac event occurred in 40
subjects (11.0 events per 1000 person-years). Table 2 lists
the cause-specific cardiovascular mortality and morbidity for
the study cohort. Only the first event within every category
was considered in the outcome analyses.
Risk AssociatedWith TDI e’ Velocity and E/e’ Ratio
Figure 2 shows the rates of sex-and-age standardized fatal
and nonfatal cardiovascular endpoints across quartiles of TDI
Table 2. Fatal and Nonfatal Cardiovascular Events
Endpoint
Number of
Events
(n=793)
Stroke Fatal 4
Nonfatal 3
Transient ischemic attack Nonfatal 5
Myocardial infarction Fatal 2
Nonfatal 3
Ischemic heart disease Fatal 2
Nonfatal 15
Coronary revascularization Nonfatal 17
Congestive heart failure Fatal 1
Nonfatal 16
Atrial fibrillation/arrhythmia Fatal 1
Nonfatal 6
Aortic aneurysm Nonfatal 2
Cor pulmonale Nonfatal 1
Arterial embolism Fatal 1
Peripheral arterial diseases Nonfatal 7
Total events 86
A B
Figure 2. Incidence rates of fatal and nonfatal cardiovascular and cardiac events by quartiles of the
distributions of the tissue Doppler imaging (TDI) e’ velocity (A) and E/e’ ratio (B) in 793 participants.
Incidence rates were calculated as number of events per 1000 subject/year and were standardized for sex
and age (age groups: <40 years; 40 to 60 years; >60 years) by the direct method. The number of endpoints
contributing to the rates is shown. P values are for trend.
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e’ velocity and E/e’ ratio. Table 3 shows the multivariable-
adjusted hazard ratios associated with every SD change in
Doppler velocities and their ratios. With adjustments applied
for family clusters, sex, age, body mass index, systolic blood
pressure, serum cholesterol, current smoking, diabetes mell-
itus, and a history of cardiac disease, TDI e’ velocity was a
significant predictor of fatal and nonfatal cardiovascular
(P=0.004) and cardiac events (P=0.001; Table 3). This finding
was also noted in models, which were additionally adjusted
for LVM index (Table 4). In adjusted models, the E/e’ ratio
was borderline associated with increased risk of cardiac
events (P=0.05; Table 3). Because of the high intra-correlation
of TDI e’ and s’ velocities (r2=0.48; P<0.0001), s’ velocity
significantly predicted composite cardiovascular and cardiac
events (P≤0.028; Table 3). However, in a Cox model including
both e’ and s’ velocities, the s’ velocity lost its prognostic
significance for both cardiovascular and cardiac events
(P≥0.16) whereas TDI e’ velocity remained significant in
predicting these events (P≤0.004). All Cox models complied
with the proportional hazards assumption. None of the other
Doppler diastolic variables significantly predicted combined
cardiovascular events (Table 3).
Risk Associated With LV Diastolic Dysfunction
At baseline, LV diastolic dysfunction groups 1, 2, and 3
included 76 (9.6%), 96 (12.1%), and 27 (3.4%) participants,
respectively. The baseline clinical and echocardiographic
characteristics of subjects by group of diastolic function
appear in Tables 5 and 6, respectively. Because LV filling
pressure (E/e’>8.5) was increased in both the second and
third groups of LV diastolic dysfunction and because the
Table 3. Adjusted Hazard Ratios for Fatal and Nonfatal Cardiovascular Events in Relation to LV Diastolic Doppler Indexes
Predictor Variable
Cardiovascular Events (n=59) Cardiac (n=40)
HR (95% CI) P Value HR (95% CI) P Value
Per SD decrease
TDI e’ 2.50 (1.33 to 4.82) 0.004 3.66 (1.68 to 7.76) 0.001
TDI a’ 1.20 (0.88 to 1.65) 0.23 1.34 (0.94 to 1.94) 0.10
TDI e’/a’ 1.63 (0.73 to 3.71) 0.22 1.75 (0.65 to 4.64) 0.25
TDI s’ 1.55 (1.04 to 2.30) 0.028 1.90 (1.15 to 3.10) 0.012
Per SD increase
E/A ratio 0.79 (0.44 to 1.42) 0.40 0.89 (0.45 to 1.75) 0.72
E/e’ ratio 1.23 (0.89 to 1.65) 0.18 1.41 (1.00 to 1.98) 0.050
Hazard ratios (HR) express the risk per standard deviation (SD) change in the Doppler diastolic velocities and its ratios. SDs were 3.7 cm/s, 2.10 cm/s, and 1.46 cm/s for TDI e’, a’, and s’
velocities and 0.65, 0.50, and 2.17 for the e’/a’, E/A, and E/e’ ratios. All hazard ratios were adjusted for family clusters, sex, age, body mass index, systolic blood pressure, serum
cholesterol, smoking, diabetes mellitus, and a history of cardiac disease. CI indicates confidence interval; LV, left ventricular; TDI, tissue Doppler imaging.
Table 4. Hazard Ratios for Fatal and Nonfatal Cardiovascular Events in Relation to LV Diastolic Doppler Parameters Additionally
Adjusted for LV Mass Index
Predictor Variable
Cardiovascular Events (n=59) Cardiac (n=40)
HR (95% CI) P Value HR (95% CI) P Value
Per SD decrease
TDI e’ 2.35 (1.28 to 4.48) 0.007 3.38 (1.52 to 7.28) 0.002
TDI a’ 1.11 (0.82 to 1.49) 0.52 1.25 (0.86 to 1.79) 0.24
TDI e’/a’ 2.00 (0.79 to 3.72) 0.17 1.80 (0.69 to 4.64) 0.22
Per SD increase
E/A ratio 0.76 (0.44 to 1.30) 0.32 0.87 (0.45 to 1.66) 0.66
E/e’ ratio 1.11 (0.83 to 1.49) 0.49 1.30 (0.92 to 1.83) 0.15
Hazard ratios (HR) express the risk per SD change in the Doppler diastolic velocities and its ratios. SDs were 3.7 cm/s and 2.10 cm/s for TDI e’ and a’ velocities and 0.65, 0.50, and 2.17
for the e’/a’, E/A and E/e’ ratios, respectively. All hazard ratios were adjusted for family clusters, sex, age, body mass index, systolic blood pressure, serum cholesterol, smoking, diabetes
mellitus, history of cardiac disease, and LV mass index. CI indicates confidence interval; LV, left ventricular; TDI, tissue Doppler imaging.
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third group represented only 3.4% of the study participants,
we combined groups 2 and 3 in the categorical survival
analysis.
Figure 3 shows cumulative incidence estimates (1-Kaplan-
Meier survival estimates) for fatal and nonfatal cardiovascu-
lar events by group of LV diastolic (dys-)function. The risk for
combined cardiovascular events increased with worsening of
LV diastolic function: from 19 in the normal group (incidence
rate, 6.9 per 1000 person-years; 95% CI, 3.8 to 10.0), 12 in
the impaired relaxation group (incidence rate, 34.6 per
1000 person-years; 95% CI, 15.0 to 54.1), and 28 in
participants with elevated LV filling pressure (incidence rate,
53.2 per 1000 person-years; 95% CI, 33.5 to 72.9). The
same trend was observed for combined cardiac events
(Figure 3). Table 7 shows the multivariable-adjusted hazard
ratios expressing the risk in each LV diastolic dysfunction
category compared with normal diastolic function. The risks
of all cardiovascular and cardiac events were significantly
elevated in participants with elevated LV filling pressure
(Table 7).
Improvement of Prognostic Accuracy
For fatal and nonfatal cardiovascular (P=0.006) and cardiac
outcome (P=0.004), IDI reached significance by adding TDI e’
to the basic model (Table 8). According to the NRI, the ability
of the Cox model to discriminate between subjects with and
without cardiovascular and cardiac events significantly
(P<0.0001) improved by adding TDI e’ to a model already
including the conventional cardiovascular risk factors
(Table 8). We did not observe significant IDI and NRI for E/
e’ ratio (Table 8).
Table 5. Baseline Clinical Characteristics of Participants by Diastolic Function Group
Characteristic
Normal Function
(n=594)
Impaired Relaxation
(n=76)
Elevated End-Diastolic
Pressure (n=96)
Combined Dysfunction
(n=27)
Transmitral E/A ratio N ↓ N ↓
E/e’ ratio N N ↑ ↑
Age, y 46.513.8 58.414.9* 67.39.4*† 67.810.4*†
Women, n (%) 291 (49.0) 32 (42.1) 62 (64.6)*† 20 (74.1)*†
Body mass index, kg/m2 25.83.9 27.93.8* 28.985.1* 29.63.3*
Systolic pressure, mm Hg 125.215.1 133.814.75* 146.119.1*† 148.817.8*†
Diastolic pressure, mm Hg 79.09.2 83.29.2* 79.49.6† 85.510.5*‡
Heart rate, beats/min 60.49.2 67.312.1* 58.168.8† 64.18.6‡
Questionnaire data
Current smoking, n (%) 131 (22.1) 19 (25.0) 13 (13.5)† 2 (7.41) †
Drinking alcohol, n (%) 261 (43.9) 26 (34.2) 24 (25.0)* 4 (14.8)*†
Hypertensive, n (%) 176 (29.6) 51 (67.1)* 77 (80.2)*† 23 (85.2)*
Treated for hypertension, n (%) 95 (16.0) 36 (47.4)* 53 (55.2)* 16 (59.3)*
Beta-blockers, n (%) 53 (8.9) 19 (25.0)* 35 (36.5)* 9 (33.3)*
ACE or ARB, n (%) 30 (5.1) 14 (18.4)* 16 (16.7)* 6 (22.2)*
Diuretics, n (%) 31 (5.2) 13 (17.1)* 26 (27.1)* 6 (22.2)*
CCB, n (%) 14 (2.4) 5 (6.6)* 10 (10.4)* 4 (14.8)*
History of CHD, n (%) 7 (1.2) 2 (2.6) 11 (11.5)*† 5 (18.5)*†
History of diabetes, n (%) 13 (2.2) 3 (3.95) 6 (6.25)* 5 (18.5)*†‡
Biochemical data
NT-proBNP, pmol/L 194 (92 to 398) 237 (115 to 456) 274 (136 to 582)* 240 (73 to 509)
Serum creatinine, lmol/L 82.713.47 89.627.97* 86.715.2 85.413.9
Total cholesterol, mmol/L 5.20.96 5.40.90 5.61.0* 5.51.0
Values are mean (SD), geometric mean (10% to 90% percentile), or number of subjects (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blockers; CCB,
calcium channel blockers; CHD, coronary heart disease; NT-proBNP, amino terminal pro-BNP.
Significance for between-groups differences: *P≤0.05 vs normal; †P≤0.05 vs impaired relaxation group; ‡P≤0.05 vs elevated end-diastolic pressure group.
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Discussion
The key findings of this study is that after adjustment for
conventional cardiovascular risk factors, LV TDI e’ velocity is a
predictor of fatal and nonfatal cardiovascular events in the
general population. We also found that TDI e’ velocity
improved the discrimination between subjects with and
without events as compared with a model including only
conventional cardiovascular risk factors, as quantified by the
IDI and NRI analyses. Furthermore, we demonstrated that
after full adjustment for important covariables, participants
with elevated LV filling pressure (moderate diastolic dysfunc-
tion) had significantly increased risks of combined cardiovas-
cular and cardiac events as compared with subjects with
normal LV diastolic function.
Echocardiography plays a central role in the evaluation of
LV diastolic function over the past 2 decades. Conventional
echocardiography together with Doppler measurements of
transmitral and pulmonary veins flows, and the TDI technique
open up the possibility of non-invasively evaluating diastolic
function.11,19 Recent clinical studies explored the prognostic
role of the new TDI-derived indexes. Three studies6–8 in
patients with symptomatic heart failure demonstrated that
high E/e’ independently predicted cardiac mortality and HF
rehospitalization. These studies provided thresholds for the
E/e’ ratio in a range from 12.5 to 15. Moreover, in the
ASCOT trial,10 E/e’ was the strongest independent predictor
of fatal and nonfatal cardiac events in a cohort of 980 high-
risk hypertensive patients. The authors demonstrated that in
an adjusted model, a 1-unit rise in the E/e’ ratio was
associated with a 17% increment in risk of cardiac events
(P=0.003) 10 Wang et al11 reported that low TDI e’ velocity
independently predicted cardiac mortality in 174 patients
with hypertension.
Only few community-based studies explored in continuous
analyses the prognostic role of the new TDI-derived veloci-
ties13 or classical pulsed-wave Doppler indexes.20,21 In 1036
participants (mean age, 60 years) enrolled in the Copenhagen
City Heart study,13 low systolic (s’) and a’ myocardial
velocities derived from Color Doppler imaging and averaged
Table 6. Baseline Echocardiographic Characteristics of Participants by Diastolic Function Group
Characteristic
Normal Function
(n=594)
Impaired Relaxation
(n=76)
Elevated End-Diastolic
Pressure (n=96)
Combined Dysfunction
(n=27)
Transmitral E/A ratio N ↓ N ↓
E/e’ ratio N N ↑ ↑
Conventional echocardiography
LA volume index, mL/m2 21.85.3 27.16.6 28.47.4*† 27.56.8*†
LV internal diameter, cm 5.020.49 5.090.58 5.070.56 4.850.49
Interventricular septum, cm 0.950.16 1.030.17* 1.070.15* 1.180.18*†‡
Posterior wall, cm 0.870.14 0.940.14* 0.970.13* 1.040.15*†
LV mass index, g/m2 88.419.3 100.132.9* 105.825.7* 115.222.2*†
Ejection fraction, % 63.46.2 61.89.0 64.07.1 64.06.9
Transmitral Doppler
E peak, cm/s 77.714.8 54.710.2* 80.813.7† 62.214.0*‡
A peak, cm/s 59.213.9 76.812.4* 82.315.5* 95.416.9*†‡
E/A ratio 1.390.46 0.730.17* 1.010.23*† 0.650.10*‡
IVRT, ms 94.614.6 110.119.3* 105.116.4* 109.521.5*
Adur-ARdur, ms 1.43 (4.3 to 7.1) 11.4 (2.8 to 28.5)* 18.5 (37.1 to 5.7)*† 16.2 (17.1 to 28.5)*‡
Tissue Doppler§
e’ peak, cm/s 12.63.26 8.502.14* 7.691.30* 5.751.14*†‡
a’ peak, cm/s 9.802.06 11.91.90* 10.41.82†* 11.41.24*
e’/a’ ratio 1.420.65 0.750.30* 0.780.20* 0.500.10*
E/e’ ratio 6.391.35 6.631.19 10.72.11*† 11.02.45*†
Values are mean (SD), or median (10% to 90% percentile). Adur indicates mitral inflow A-wave duration; ARdur, pulmonary vein reversal flow duration; IVRT, isovolumetric relaxation time;
LA, left atrial; LV, left ventricle.
Significance for between-groups differences: *P≤0.05 vs normal; †P≤0.05 vs impaired relaxation group; ‡P≤0.05 vs elevated LV filling pressure group.
§Averaged of septum, lateral, inferior, and posterior mitral annulus sites.
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from 6 myocardial segments independently predicted total
mortality. In this study, the averaged e’, E/A and E/e’ ratios
had no independent predictive value.13 In our current study,
low e’ derived from pulsed TDI predicted combined cardio-
vascular and cardiac outcomes over and beyond conventional
risk factors. Moreover, the E/e’ ratio was borderline associ-
ated with an increased risk of cardiac events. Differences in
recording of TDI velocities between the Danish and our study
might explain this discrepancy. Indeed, Mogelvang et al13
reconstructed mean TDI velocities curves from 2D color-
coded TDI images, whereas, in our study, we derived maximal
myocardial velocities from spectral pulsed TDI curves
recorded at the level of mitral annulus. Overall, Color Doppler
e’ velocity reported by Mogelvang et al13 was about 38%
lower than pulsed TDI e’ velocity in our study (7.1 cm/s
versus 11.4 cm/s). Moreover, the Mogelvang’s study13
considered only total mortality, which includes noncardiovas-
cular endpoints.
Two community-based studies explored the prognostic role
of transmitral Doppler E/A ratio. In the Cardiovascular Health
Study (mean age, 73 years),20 the adjusted risk of symptom-
atic heart failure was highest at the extremes of the
distribution of the E/A ratio. The relative risk was 1.88
(95% CI, 1.33 to 2.68) for an E/A ratio of less than 0.7 and
3.50 (CI, 1.80 to 6.80) for an E/A ratio higher than 1.5,
compared with intermediate values. Moreover, among 3008
American Indians (mean age, 60 years) enrolled in the Strong
Heart Study,21 all-cause and cardiac mortality also had a
U-shaped relation with the E/A ratio. In our study, we did not
observe significant associations between combined cardio-
vascular outcome and E/A. These findings have to be
interpreted, keeping in mind that, in our study age averaged
50.9 years, and the proportion of participants with hyperten-
sion was 41.2%.
To our knowledge, only one community-based study
explored the predictive value of LV diastolic dysfunction
grades based on conventional Doppler and new TDI veloc-
ities.4 In the Olmsted study4 mild LV diastolic dysfunction
(hazard ratio, 8.31; P<0.001) and moderate or severe
diastolic dysfunction (10.2; P<0.001) predicted all-cause
A
B
Figure 3. Cumulative incidence estimates (1-Kaplan-Meier sur-
vival estimates) for all cardiovascular and cardiac events. Normal
left ventricular (LV) diastolic function is normal E/A and E/e’;
impaired relaxation is low age-specific E/A and normal E/e’;
elevated LV filling pressure is high E/e’. P values are for the
differences between groups by the log-rank test. LVDD indicates
left ventricular diastolic dysfunction.
Table 7. Adjusted Hazard Ratios Associated With LV Diastolic Dysfunction Versus Normal Function at Baseline
LV Diastolic Function Group Total N
Fatal and Nonfatal Events
All Cardiovascular (n=59) Cardiac (n=40)
N of Events HR (95% CI) P Value N of events HR (95% CI) P Value
Normal 554 19 Referent 10 Referent
Impaired relaxation (group 1) 76 12 1.77 (0.75 to 4.17) 0.17 7 2.13 (0.70 to 6.47) 0.17
Elevated LV filling pressure
(group 2 and 3)
123 28 2.21 (1.01 to 4.83) 0.042 23 4.50 (1.73 to 11.7) 0.002
Hazard ratios (HR) express the risk in each group of left ventricular diastolic dysfunction at baseline compared with the risk in the subjects with normal function at baseline. All hazard
ratios were adjusted for family clusters, sex, age, body mass index, systolic blood pressure, serum cholesterol, smoking, diabetes mellitus, and history of cardiac disease. CI indicates
confidence interval; LV, left ventricular.
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mortality, while controlling for sex, age, and ejection
fraction. However, the Olmsted researchers did not adjust
for other cardiovascular risk factors. In our study, we used a
similar approach to grade LV diastolic dysfunction as in the
Olmsted Study, but at variance with grading applied by
Redfield et al we utilized age-specific criteria for transmitral
E/A ratio and also considered LAVI in grading LV diastolic
function. Our fully adjusted hazard ratios indicated, com-
pared with participants with normal diastolic function, a
2-fold increased risk of a cardiovascular event and a 4-fold
higher risk of a cardiac event in participants with an
elevated LV filling pressure. Furthermore, we noticed
progressive lowering of TDI e’ velocity in participants with
an impaired relaxation pattern (8.50 cm/s), and in those
with elevated end-diastolic pressure (7.69 cm/s and
5.75 cm/s) compared to subjects with normal diastolic
function (12.6 cm/s; Table 6).
Our study has to be interpreted within the context of its
potential limitations and strengths. First, the Doppler blood
flow measurements and the TDI velocities are prone to
measurement error. In the present study, one experienced
observer recorded all Doppler images using a highly stan-
dardized imaging protocol. All digitally stored images were
centrally post-processed by a single observer. Second, our
sample size was smaller than in published community-based
studies. We, therefore, could not rule out that the associa-
tions that failed to reach statistical significance were due to a
type II error. However, the research question addressed in
this study and our conclusions were expanding the findings of
previous publications in patients with heart failure6–9 and
hypertension.11 Third, we included in our analysis 27 (3.4%)
participants with a previous history of cardiac diseases from
whom 14 participants experienced recurrent cardiovascular
event during follow-up. However, with adjustment for previous
cardiac disease applied, TDI e’ was significantly associated
with increased risk of cardiovascular and cardiac events
(Table 3). Previous community-based studies, which explored
the predictive value of TDI indexes13 or LV diastolic
dysfunction grades4 included in the outcome analyses up to
11% participants with a previous coronary events. Further-
more, in a sensitivity analysis, after exclusion participants
with previous cardiac diseases, our findings remained
consistent (data not shown). Fourth, patterns of transmitral
flow and mitral annulus velocities also depend on the
compliance and contractile function of the left atrium. Thus,
we did not evaluate LV diastolic function in participants with
sustained atrial fibrillation. Fifth, because in our study we
included only white European populations, the generalizability
of the findings to other ethnicities is currently limited and
should also be further explored by additional research.
In conclusion, low early diastolic mitral annulus velocity
measured by TDI significantly predicted higher fatal and
nonfatal cardiovascular events. TDI e’ represents a simple
echocardiographic measure which might be used for assess-
ing cardiovascular risk in a general population. Furthermore,
the risk of a cardiovascular or cardiac complication substan-
tially increases in the diastolic dysfunction characterized by
elevated LV filling pressure.
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